5-Amino-1MQ 5mg

Quickstart Highlights

5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) studied for its metabolic effects in preclinical models[1][2]. By blocking NNMT, it preserves cellular NAD⁺ levels and shifts metabolism in adipose tissue toward increased energy expenditure and reduced fat storage[1][3]. This educational protocol presents a once-daily subcutaneous approach with gradual titration based on research in diet-induced obese mice.

Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
Typical daily range: 150–600 mcg once daily (gradual titration over 8 weeks).
Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Week	Daily Dose (mcg)	Units (per injection) (mL)
Weeks 1–2	150 mcg	4.5 units (0.045 mL)
Weeks 3–4	300 mcg	9.0 units (0.090 mL)
Weeks 5–8	600 mcg	18 units (0.18 mL)

Frequency: Inject once daily subcutaneously. A conservative once-daily regimen is presented, since sustained daily NNMT inhibition has shown efficacy in animal studies[1][4]. This stepwise titration allows monitoring of tolerance while gradually reaching effective dosing levels observed in preclinical research[1][4]. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

Reference-derived details for 5-Amino-1MQ 5mg.

Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration.

Peptide Vials (5-Amino-1MQ, 10 mg each):
Peptide Vials (5-Amino-1MQ, 10 mg each):: 8 weeks ≈ 3 vials
Peptide Vials (5-Amino-1MQ, 10 mg each):: 12 weeks ≈ 4 vials
Peptide Vials (5-Amino-1MQ, 10 mg each):: 16 weeks ≈ 6 vials
Insulin Syringes (U-100):
Insulin Syringes (U-100):: Per week: 7 syringes (1/day)
Insulin Syringes (U-100):: 8 weeks: 56 syringes
Insulin Syringes (U-100):: 12 weeks: 84 syringes
Insulin Syringes (U-100):: 16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.: 8 weeks (3 vials): 9 mL → 1 × 10 mL bottle
Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.: 12 weeks (4 vials): 12 mL → 2 × 10 mL bottles
Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.: 16 weeks (6 vials): 18 mL → 2 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: Per week: 14 swabs (2/day)
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 8 weeks: 112 swabs → recommend 2 × 100-count boxes
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 12 weeks: 168 swabs → recommend 2 × 100-count boxes
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 16 weeks: 224 swabs → recommend 3 × 100-count boxes

Protocol Overview

Concise summary of the once-daily regimen.

Goal: Support metabolic improvements and fat reduction through NNMT inhibition[2][4]. Open source
Schedule: Daily subcutaneous injections for 8 weeks (may extend as needed).
Dose Range: 150–600 mcg daily with gradual titration.
Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

Suggested daily titration approach.

Start: 150 mcg daily for 2 weeks to assess tolerance.
Mid-Phase: Increase to 300 mcg daily for weeks 3–4.
Target: 600 mcg daily by weeks 5–8.
Frequency: Once per day (subcutaneous).
Cycle Length: 8 weeks minimum; may extend based on research goals.
Timing: Any consistent time; rotate injection sites.

Storage Instructions

Proper storage preserves compound quality.

Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure[8]. Open source
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); prepare aliquots if needed and avoid freeze–thaw[9]. Open source
Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes; dispose in a sharps container. mg/mL concentration.
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
Inject slowly; wait a few seconds before withdrawing the needle.
Document daily dose and site rotation to maintain consistency.
Consider 30-unit or 50-unit syringes for small-volume doses (≤0.10 mL) to improve measurement accuracy.

How This Works

5-Amino-1MQ inhibits the enzyme nicotinamide N-methyltransferase (NNMT), which leads to preservation of cellular NAD⁺ levels and shifts metabolism in adipose tissue[1][3]. By blocking NNMT, it reduces 1-methylnicotinamide formation and alters the methionine/SAM cycle, thereby promoting increased energy expenditure and reduced fat storage at the cellular level. In diet-induced obese mice, 5-Amino-1MQ significantly reduced body weight and adiposity without affecting food intake[1], and in aged mice it improved muscle strength and metabolic markers, validating NNMT as a therapeutic target in metabolism[4].

Potential Benefits & Side Effects

Observations from preclinical research (no human clinical trials published to date).

Significant reductions in body weight and adiposity observed in obese mice without changes in food intake[1]. Open source
Improved muscle strength and metabolic markers in aged mice, demonstrating multi-tissue metabolic benefits[4]. Open source
Animal data indicated 5-Amino-1MQ was well-tolerated without adverse effects at effective doses[1]. Open source
Occasional mild injection-site reactions (redness/itch) may occur with subcutaneous administration.

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and skin with alcohol; allow to dry[5]. Open source
Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[5][6]. Open source
Do not aspirate for subcutaneous injections; inject slowly and steadily[7]. Open source
Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[5][6]. Open source
Do not rub the injection site; apply light pressure with gauze if needed.

Lifestyle Factors

Complementary strategies for best outcomes.

Pair with a balanced, protein-forward diet tailored to energy needs.
Combine resistance training and aerobic activity to reinforce metabolic adaptations.
Prioritize sleep and stress management to support adherence and recovery.
Monitor body composition changes rather than scale weight alone.

Recommended Source

We recommend Pure Lab Peptides for high-purity 5-Amino-1MQ (10 mg).

Start: 150 mcg daily for 2 weeks to assess tolerance.
Mid-Phase: Increase to 300 mcg daily for weeks 3–4.
Target: 600 mcg daily by weeks 5–8.
Frequency: Once per day (subcutaneous).
Cycle Length: 8 weeks minimum; may extend based on research goals.
Timing: Any consistent time; rotate injection sites.

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

References